Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells
Authors:
- Jérôme GalonJGJérôme Galon
- Galina KaraschukGKGalina Karaschuk
- Diana DudziakDDDiana Dudziak
- Mathieu CamusMCMathieu Camus
- Vladimir LazarVLVladimir Lazar
- Sophie Camilleri-BroëtSCSophie Camilleri-Broët
- Christine Lagorce-PagèsCLChristine Lagorce-Pagès
- Sophie Lebel-BinaySLSophie Lebel-Binay
- Gerhard LauxGLGerhard Laux
- Wolf-Herman FridmanWFWolf-Herman Fridman
- Berthold HengleinBHBerthold Henglein
Open Access
- 15 February 2005
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 105 (4) , 1632-1639
Abstract
Epstein-Barr virus (EBV) latently infects and immortalizes B lymphocytes and causes lymphoproliferative malignancies. We show here that the EBV nuclear antigen EBNA2 induces expression of the 2 chains of the interleukin-18 receptor (IL-18R) in Burkitt lymphoma (BL) cell lines and in nontransformed B cells. Activation of IL-18R expression by EBNA2 is independent of its interaction with the transcriptional repressor RBPJκ. It occurs in the absence of any other viral protein but requires de novo synthesis of cellular proteins. IL-18R induction is a highly specific function of EBNA2, because neither other EBV latent proteins nor the cellular proteins c-myc or Notch can exert this effect. Using cDNA microarray expression profiling, we find that the IL-18 receptor expressed in EBV-infected BL cells has signaling capacity, because IL-18 significantly modified gene expression. We report that EBNA2 expression is associated with IL-18R expression in vivo in EBV-positive B-lymphomas from AIDS patients. (Blood. 2005;105:1632-1639)Keywords
This publication has 65 references indexed in Scilit:
- IL‐18 is produced by prostate cancer cells and secreted in response to interferonsInternational Journal of Cancer, 2003
- Antagonistic effects ofc-myc and Epstein-Barr virus latent genes on the phenotype of human B cellsInternational Journal of Cancer, 2001
- Cell cycle activation by c-myc in a Burkitt lymphoma model cell lineInternational Journal of Cancer, 2000
- Lymphotoxin acts as an autocrine growth factor for Epstein‐Barr virus‐transformed B cells and differentiated Burkitt lymphoma cell linesEuropean Journal of Immunology, 1994
- EBNA‐2 and EBNA‐LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein‐Barr virus.The EMBO Journal, 1994
- The epstein‐barr virus latent membrane protein‐1 (LMP1) induces interleukin‐10 production in burkitt lymphoma linesInternational Journal of Cancer, 1994
- The Epstein‐Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis‐element of the terminal protein 1 gene promoter.The EMBO Journal, 1993
- Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein‐Barr virus (EBV)International Journal of Cancer, 1990
- Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells.The EMBO Journal, 1987
- Expression of B‐cell‐specific markers in different burkitt lymphoma subgroupsInternational Journal of Cancer, 1987